O
The startup develops AI technology that accelerates molecular discovery by utilizing machine learning algorithms to analyze molecular activity for precise identification of potential drug compounds. This approach enhances the efficiency of drug compound discovery and simplifies virtual screening benchmarks for pharmaceutical companies.
Updated 3 months ago
Funding
$30.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Features
- The startup develops AI technology that accelerates molecular discovery by utilizing machine learning algorithms to analyze molecular activity for precise identification of potential drug compounds. This approach enhances the efficiency of drug compound discovery and simplifies virtual screening benchmarks for pharmaceutical companies.